药品名称EULEXIN
申请号018554产品号001
活性成分FLUTAMIDE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格125MG
治疗等效代码参比药物
批准日期1989/01/27申请机构SCHERING CORP SUB SCHERING PLOUGH CORP
化学类型New molecular entity (NME)审评分类Priority review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
018554023APLabel2003/04/14下载
018554022APLetter2001/03/30下载
018554022APReview2005/01/28下载
018554021APLetter2001/03/23下载
018554021APReview2005/01/28下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
018554023AP2001/07/23Labeling Revision
018554022AP2001/03/30Labeling Revision
018554021AP2001/03/23Labeling Revision
018554020AP2001/03/14Control Supplement
018554019AP2001/01/23Manufacturing Change or Addition
018554018AP2000/01/07Manufacturing Change or Addition
018554017AP1998/05/18Control Supplement
018554016AP1997/11/12Control Supplement
018554015AP1999/08/19Labeling Revision
018554014AP1996/06/21New or Modified Indication
018554013AP1995/11/15Manufacturing Change or Addition
018554012AP1995/09/15Labeling Revision
018554011AP1994/10/26Labeling Revision
018554010AP1991/09/19Labeling Revision
018554009AP1992/05/18Manufacturing Change or Addition
018554008AP1993/07/22Manufacturing Change or Addition
018554005AP1991/05/07Control Supplement
018554004AP1996/08/30Control Supplement
018554003AP1990/09/03Labeling Revision
018554002AP1992/07/29Manufacturing Change or Addition
018554001AP1989/10/17Labeling Revision
018554000AP1989/01/27Approval